Back
ARS Pharmaceuticals Vs. Aquestive Therapeutics Industry Stock Comparison
Sell
35
SPRY
ARS Pharmaceuticals
Last Price:
14.87
Seasonality Move:
-2.91%
Buy
63
AQST
Aquestive Therapeutics
Last Price:
5.20
Seasonality Move:
11.7%
Sell
35
ARS Pharmaceuticals (SPRY)
is a Sell
Is ARS Pharmaceuticals a Buy, Sell or Hold?
- The current ARS Pharmaceuticals [SPRY] share price is $14.05. The Score for SPRY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- SPRY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Aquestive Therapeutics (AQST)
is a Buy
Is Aquestive Therapeutics a Buy, Sell or Hold?
- The current Aquestive Therapeutics [AQST] share price is $4.95. The Score for AQST is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- AQST is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SPRY Stock Price Chart
What is ARS Pharmaceuticals's stock price today?
-
The ARS Pharmaceuticals share price today is $14.05
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPRY is experiencing buying pressure, which is a positive indicator for future bullish movement.
AQST Stock Price Chart
What is Aquestive Therapeutics's stock price today?
-
The Aquestive Therapeutics share price today is $4.95
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AQST is experiencing slight buying pressure.
SPRY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 63.23 | Buy |
| Chaikin Money Flow: | 629993 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.04 - 13.82) | Buy |
| Bollinger Bands (100): | (8.53 - 12.15) | Buy |
AQST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.27 | Buy |
| Relative Strength Index (14 RSI): | 61.82 | Buy |
| Chaikin Money Flow: | 96799 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.2 - 4.76) | Buy |
| Bollinger Bands (100): | (2.69 - 4.15) | Buy |
SPRY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.65 | Buy |
| 20-day SMA: | 12.71 | Buy |
| 50-day SMA: | 11.83 | Buy |
| 200-day SMA: | 8.83 | Buy |
| 8-day EMA: | 12.95 | Buy |
| 20-day EMA: | 12.6 | Buy |
| 50-day EMA: | 11.79 | Buy |
| 200-day EMA: | 9.39 | Buy |
AQST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.79 | Buy |
| 20-day SMA: | 4.56 | Buy |
| 50-day SMA: | 3.89 | Buy |
| 200-day SMA: | 3.32 | Buy |
| 8-day EMA: | 4.76 | Buy |
| 20-day EMA: | 4.52 | Buy |
| 50-day EMA: | 4.05 | Buy |
| 200-day EMA: | 3.28 | Buy |
ARS Pharmaceuticals Earnings Growth & SPRY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.15 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.26 per share.
Aquestive Therapeutics Earnings Growth & AQST Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.12 per share.
ARS Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aquestive Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||